News
Cancer risk after radioiodine for hyperthyroidism ‘small’: Meta-analysis
- Author:
- Nancy A. Melville
Studies showing a linear dose-response risk warrant further research, but overall assessment of risks called “reassuring.”
News

Menopause society issues first osteoporosis advice in 10 years
- Author:
- Nancy A. Melville
In the first update since 2010, the North American Menopause Society addresses new advances, including use of novel agents to prevent “bone...
News
Molecular ‘theranostics’ could guide treatment in thyroid cancer
- Author:
- Nancy A. Melville
“The new paradigm calls for identifying, through molecular analysis, the cancers that have the ability to respond to RAI and/or those that could...
News
Better to binge drink than regularly tipple, suggests GI cancer study
- Author:
- Nancy A. Melville
“Repeated alcohol consumption events even at lower amounts of alcohol may have a greater carcinogenic effect on...
News

US Preventive Services Task Force lowers diabetes screening age for overweight
- Author:
- Nancy A. Melville
In an updated recommendation, the USPSTF lowers the screening age for prediabetes and diabetes from 40 to 35...
News

Polygenic breast cancer risk scores strive to overcome racial bias
- Author:
- Nancy A. Melville
Shortcomings in datasets, particularly for women of African descent, hinder their clinical use. Efforts...
News

Endocrinologists’ wealth remains steady, despite pandemic
- Author:
- Nancy A. Melville
The latest wealth and debt report shows few changes; gender disparities in wealth are notable.
News

Low glycemic diet improves A1c, other risk factors in diabetes
- Author:
- Nancy A. Melville
A meta-analysis that incorporates the most recent research on the topic shows important benefits of a low glycemic diet for people with diabetes...
News

ARBs equal ACE inhibitors for hypertension, and better tolerated
- Author:
- Nancy A. Melville
Although ACE inhibitors are more commonly prescribed, new findings from almost 3 million patients support starting with ARBs as first-time...
News

Two-drug dolutegravir treatment noninferior to 3/4 drug regimen
- Author:
- Nancy A. Melville
The fixed-dose dolutegravir-based regimen shows noninferiority versus any ART regimens, while also showing feasibility as a first-line treatment...
News
HIV-associated cryptococcal meningitis: Single-dose regimen found non-inferior
- Author:
- Nancy A. Melville
Mortality from cryptococcal meningitis with a single-dose regimen of liposomal amphotericin B is similar to the...
News
Twice-a-year lenacapavir shows viral suppression in drug-resistant HIV at 26 weeks
- Author:
- Nancy A. Melville
“According to its long half-life of two subcutaneous injections per year, [it] could help reduce pill burden.”
News
Resistant TB: Adjustments to BPaL regimen reduce AEs, not efficacy
- Author:
- Nancy A. Melville
Lower doses of linezolid in the BPaL regimen reduce the adverse events in patients with highly drug-resistant...
News

Levothyroxine overprescribing common, consistent over time
- Author:
- Nancy A. Melville
A study detailing the consistent overuse of the thyroid replacement drug over a decade should be a “call to action” for doctors to stop treating...
News
Reduced-intensity transplant benefits older patients with AML
- Author:
- Nancy A. Melville
This improvement in survival is seen regardless of key factors such as genotype and the status of minimal...